Pathogenetic therapeutic decision of immunotherapy in the patients with infection-dependent bronchial asthma.

摘要

Efficacy of the methods of immunotherapy in the treatment of infection-dependent bronchial asthma is discussed up to date. This work is devoted to the study of efficacy of different immunotherapy methods (allergen-specific immunotherapy with Neisseria Perflava and immunotherapy with Rusam) and its prescription according to the pathogenesis of disease in the patients with infection-dependent bronchial asthma.